Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 1, 2013, Pages 154-160

  Ueno, Yoshiko ^a   Kitajima, Kazuhiro ^a   Sugimura, Kazuro ^a   Kawakami, Fumi ^a   Miyake, Hideaki ^a   Obara, Makoto ^b   Takahashi, Satoru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

3 T MRI; b = 2000 s mm2; diffusion weighted imaging (DWI); prostate cancer; ultra high b value

Indexed keywords

GADOLINIUM CHELATE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

3-T MRI; B = 2000 S/MM2; DIFFUSION-WEIGHTED IMAGING (DWI); PROSTATE CANCER; ULTRA-HIGH B-VALUE;

AGED; ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84880125940     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23953     Document Type: Article

References (22)

1. Siegel R, Ward E, Brawley O, Jemal A,. Cancer statistics, 2011. CA Cancer J Clin 2011; 61: 212-236.
2. Tan N, Margolis DJ, McClure TD, et al. Radical prostatectomy: value of prostate MRI in surgical planning. Abdom Imaging 2012; 37: 664-674.
3. Blute M, Bostwick DG, Bergstralh EJ, et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 1997; 50: 733-739.
4. Hricak H, Choyke PL, Eberhardt SC, Leibel S, Scardino PT,. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 213: 481-488.
5. Chen M, Dang HD, Wang JY, et al. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008; 49: 602-610.
6. Aydn H, Kzlgöz V, Tatar IG, et al. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy correlated with biopsy and histopathological findings. J Comput Assist Tomogr 2012; 1: 30-45.
7. Haider MA, Vander Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007; 189: 323-328.
8. Portalez D, Rollin G, Leandri P, et al. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 2010; 20: 2781-2790.
9. Yoshizako T, Wada A, Hayashi T, et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008; 49: 1207-1213.
10. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S,. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152.
11. 2. AJR Am J Roentgenol 2010; 194: 33-37.
12. Kitajima K, Kaji Y, Kuroda K, Sugimura K,. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 2008; 7: 93-99.
13. Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K,. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 2010; 31: 625-631.
14. Katahira K, Takahara T, Kwee TC, et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011; 21: 188-196.
15. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792.
16. Cruz M, Tsuda K, Narumi Y, et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 2002; 12: 357-365.
17. Kundel HL, Polansky M,. Measurement of observer agreement. Radiology 2003; 228: 303-308.
18. Metens T, Miranda D, Absil J, Matos C,. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 2012; 22: 703-709.
19. 2). J Magn Reson Imaging 2012; 36: 198-205.
20. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008; 248: 531-539.
21. Yu KK, Hricak H,. Imaging prostate cancer. Radiol Clin North Am 2000; 38: 59-85.
22. Janssen MJ, Huijgens PC, Bouman AA, Oe PL, Donker AJ, van der Meulen J,. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant 1993; 8: 1228-1233.